- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03003689
Effects of Scaling and Root Planing With and Without Er:YAG Laser in Chronic Periodontitis Patients
Randomized Clinical Trial Assessing the Clinical Outcomes and Recolonization Patterns Following Scaling and Root Planing With and Without Using Er.YAG Laser in Chronic Periodontitis Patients
Dental bacterial plaque is the most frequent modifiable finding in patients with periodontal (gum) diseases. Many studies have provided evidence that mechanical removal of dental plaque is critical for improving the periodontal health. The standard initial treatment of periodontitis (gum disease) is to remove plaque and calculus form the teeth and root structures using sclaing and root planing (SRP). Typically hand instruments and an ultrasonic scaler are used for SRP
While this method removes some of the bacteria that leads to periodontitis, microorganisms are not completely eliminated through SRP. Studies have shown that after 3 months, the bacteria initially present prior to scaling and root planing had recolonized. In order to prevent recurrence of periodontitis, it is recommended that oral bacteria be kept at low levels.
When used at the proper wave length, dental lasers have been shown to effectively removes calculus, without damaging surrounding tissue. The Er:YAG laser has been FDA-approved for the use of scaling and root planing in Dentistry. While studies on the Er:YAG laser have shown that it is effective in removing calculus and preserving the tooth root structure, there is no consensus of the level of calculus removal. The Er:YAG laser may also be more effective in removing microbial bacteria than SRP with hand instruments and ultrasonic scaler.
The purpose of this study is to evaluate the effectiveness of the Er:YAG laser, as an adjunct to scaling and root planing, in removing microbial bacteria. Participants with chronic periodontitis will be randomized to have one quadrant undergo scaling and root planing using hand instruments and ultrasonic scaler alone, while a second quadrant will receive the same treatment, with the addition of the Er:YAG laser. Outcomes studies will be traditional periodontal clinical parameters at 6 weeks and 3 months after treatment. Microbial cultures will be performed at baseline and 3 months to compare survival and re-population by periodontal microorganisms.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Primary Aim: The primary aim of this study is to evaluate the efficacy of Er:YAG laser as an adjunct to mechanical scaling and root planing periodontal therapy by comparing probing depth and clinical attachment levels.
Secondary aim: The secondary aim of this study is to evaluate the efficacy of Er:YAG laser as an adjunct to mechanical scaling and root planing periodontal therapy by comparing gingival bleeding index and plaque index.
Tertiary aim: The tertiary aim of this study is to compare the microbial outcomes of mechanical periodontal therapy alone vs. mechanical therapy combined followed with Er:YAG laser therapy at the same time.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Massachusetts
-
Boston, Massachusetts, United States, 02111
- Recruiting
- Tufts University School of Dental Medicine
-
Principal Investigator:
- Charles Hawley, DDS, MS, PhD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patients enrolled in the Post-Graduate Periodontology Clinic at Tufts University School of Dental Medicine (TUSDM)
- Recent (within the past 30 days) diagnosis of moderate to severe chronic periodontitis in at least two quadrants according to the Armitage Classification
- Have had full mouth and vertical bite-wing series of diagnostic radiographs exposed at TUSDM within 6 months preceding entry of the study as a standard of care
- Have a treatment plan made by the original provider and certified by the PI based on the working diagnosis, presenting etiology, and the predicted therapeutic outcomes of the case (prognosis).
- Each of the two selected quadrants should have at least 5 teeth including the canine, first premolar and second premolar in contact with at least one tooth that has ≥ 5 mms and ≤ 9 mms probing depths with bleeding on probing.
Exclusion Criteria:
- Participants must not have had mechanical debridement or any other professional periodontal therapy within 6 months preceding entering the study
- Participants with significant chronic oral soft tissue pathology (lichen planus, Benign Mucous Membrane Pemphigoid, Steven Johnson's Syndrome, Sjogren's Syndrome, etc.) which might affect host response to the presence of bacteria.
- Participants with fixed appliances or partial dentures, to standardize the effect of the treatment since they are plaque retentive.
- Participants who smoke tobacco
- Participants who require prophylactic antibiotics prior to dental treatment
- Participants who have taken systemic antibiotic medications within the previous 6 months
- Participants with uncontrolled systemic conditions or disease such as diabetes and immunological disorders
- Participants with known drug allergies or known adverse effects following the use of oral hygiene products.
- Participants who are pregnant or lactating
- Teeth with grade III mobility or teeth with hopeless prognosis indicated for extraction
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Scaling and Root Planing
Hand instruments + ultrasonic scaler PD, CAL, plaque index and gingival bleeding index will be measured at baseline, 6 weeks and 3 months. Microbial load will be measured at baseline and 3 months. |
Standard of care scaling and root planing using hand instruments and ultrasonic scaler
|
|
Experimental: Scaling and Root Planing + Er:YAG Laser
Er:YAG Laser, hand instruments + ultrasonic scaler PD, CAL, plaque index and gingival bleeding index will be measured at baseline, 6 weeks and 3 months. Microbial load will be measured at baseline and 3 months. |
Standard of care scaling and root planing using hand instruments and ultrasonic scaler
Er:YAG laser as an adjunct therapy to standard of care scaling and root planing using hand instruments and ultrasonic
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Probing Depth
Time Frame: Up to 3 months
|
Differences in pocket depth reduction between laser treatment and control groups will be analyzed with a linear mixed effects model.
Four sites (mesiolingual, mesiobuccal, distolingual, and distobuccal) per tooth will be averaged and used in the linear mixed effects model.
Normality of the data will be assessed graphically and with the Shapiro-Wilk test.
|
Up to 3 months
|
|
Change in Clinical Attachment Levels
Time Frame: Up to 3 months
|
Differences in attachment gain between laser treatment and control groups will be analyzed with a linear mixed effects model.
Four sites (mesiolingual, mesiobuccal, distolingual, and distobuccal) per tooth will be averaged and used in the linear mixed effects model.
Normality of the data will be assessed graphically and with the Shapiro-Wilk test.
|
Up to 3 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Gingival Bleeding Index
Time Frame: Up to 3 months
|
The gingival bleeding index (the number of bleeding sites divided by the total number of sites) will be calculated.
Statistical significance between the two groups' gingival bleeding index will be determined with generalized estimating equations.
|
Up to 3 months
|
|
Change in Plaque Index
Time Frame: Up to 3 months
|
The plaque index (the number of surfaces with plaque divided by the total number of surfaces) will be calculated.
Statistical significance between the two groups' plaque index will be determined with generalized estimating equations.
|
Up to 3 months
|
|
Change in microbial load, measured in Colony Forming Units (CFUs)
Time Frame: baseline, 3 months
|
Microbial load will be measured by the total number of cultivable bacteria measured by total viable colony forming units (CFUs) on non-selective and selective media. Percent cultivability of periodontal pathogens will be measured by number of pathogen specific CFUs in proportion to total cultivability. Differences in microbial load will be investigated with the paired t-test. If the assumption of normality is unmet, the Wilcoxon rank-sum test will be used instead. |
baseline, 3 months
|
Collaborators and Investigators
Investigators
- Principal Investigator: Charles Hawley, DDS, MS, PhD, TUSDM
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 12321
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Chronic Periodontitis
-
Mahsa UniversityRecruitingPeriodontitis | Periodontitis Chronic Generalized Moderate | Periodontitis (Stage 3) | Periodontitis, Adult | Periodontitis Chronic Generalized Severe | Periodontitis, Chronic | Periodontitis Stage II | Periodontitis Chronic Localized Slight | Periodontitis Stage IIIMalaysia
-
Columbia UniversityCompletedPeriodontal Diseases | Generalized Moderate Chronic Periodontitis | Generalized Severe Chronic PeriodontitisUnited States
-
Gulf Medical UniversityCompletedPeriodontitis | Chronic Periodontitis (Disorder)United Arab Emirates
-
University Hospital HeidelbergRecruitingPeriodontitis (Stage 3) | Periodontitis, Adult | Periodontitis Stage IVGermany
-
Loma Linda UniversityTerminated
-
Jorge GamonalUnknown-Chronic PeriodontitisChile
-
Government College of Dentistry, IndoreUnknown
-
Institute of Biophysics and Cell Engineering of...Belarusian Medical Academy of Post-Graduate EducationCompletedPeriodontitis, ChronicBelarus
-
Institute of Dental Sciences, Bareilly, Uttar Pradesh...UnknownCHRONIC PERIODONTITIS
-
Universidade Estadual Paulista Júlio de Mesquita...CompletedChronic Periodontitis ComplexBrazil
Clinical Trials on Scaling and Root Planing
-
University of NebraskaCompletedPeriodontal Diseases | Periodontitis, Apical, Chronic Nonsuppurative | Suppuration of Gingival CreviceUnited States
-
University of CataniaCompletedPeriodontal DiseasesItaly
-
Institut Straumann AGCompleted
-
Mohammed Bin Rashid University of Medicine and...RecruitingPeriodontal DiseasesUnited Arab Emirates
-
University of BaghdadNot yet recruiting
-
Kutahya Health Sciences UniversityCompletedPeriodontitis | Gingivitis | Dental Anxiety | Dental Fear | Calculus, DentalTurkey
-
University of MessinaCompleted
-
University of MichiganCompletedPeriodontal Diseases | Dental DiseasesUnited States
-
Dr.K.Sai PriyankaPanineeya Mahavidyalaya Institute of Dental Sciences & Research CentreCompletedGingivitis and Periodontal Diseases
-
Panineeya Mahavidyalaya Institute of Dental Sciences...CompletedChronic Periodontitis | Renal Insufficiency Chronic